Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

MedWand Solutions, Inc. To Showcase The Evolution Of Telemedicine At CES 2022 In Las Vegas Jan 5-8, 2022

Leading the way in delivering digital healthcare technologies for clinicians and patients, MedWand Solutions will showcase the latest developments of its award-winning product at the upcoming 2022 Consumer Electronics Show (CES), the world’s largest technology trade show, January 5-8, 2022 in Las Vegas.

Recommended AI News: Abacus.AI Named a 2021 Gartner Cool Vendor

Transforming the current capabilities of telemedicine, MedWand will demonstrate how clinicians can perform real-time clinically accurate, multi-diagnostic examinations of their patients, using a single handheld device from anywhere in the world.

This groundbreaking technology brings physical exams into the virtual world, and at CES 2022 MedWand will showcase live demonstrations by a physician who will conduct comprehensive video consultations and physical exams over the Internet, including real-time monitoring and recording of key vitals. Collected data can include core temperature, blood oxygen saturation and pulse rate, heart, lung and abdominal auscultations, electrocardiogram, and high definition otoscopic, oropharynx, and dermatoscopic exam images. MedWand will also demonstrate the seamless capture of 3rd party vitals such as blood pressure, blood sugar, spirometry, weight, and body mass data, all integrated with popular EHR and patient management solutions to support scheduling of exams and export of all captured data into the EHR.

MedWand will also announce that it is now able to host FDA-approved AI (Anomaly Indication) algorithms through its cloud-based and scalable VirtualCare software platform. This capability further advances the science of telemedicine by enabling low cost screening for life threatening conditions that might be missed by primary providers unfamiliar with the symptoms.

Related Posts
1 of 26,502

Recommended AI News: Sukna Ventures and Unifonic Close Their Successful Entrepreneurial Program with Demo Day Presentations  

“CES is the largest and most anticipated event in the tech space, and we are excited to show the expansion of MedWand into a complete ecosystem to comprehensively monitor the health and general wellbeing of individuals from anywhere, at any time,” shared MedWand CEO and Co-Founder Robert Rose. “As a company dedicated to advancing the future of healthcare, we are proud to offer solutions that could lead to lowering costs, improving health equity, and saving lives.”

PREDICTIONS-SERIES-2022

The ergonomic MedWand and associated cloud-based software platform were created by a team of physicians and medical device engineers to enhance the quality and accessibility of health care services for clinicians and patients, regardless of physical location. The company offers MedWand and VirtualCare software for applications that include hospitals, field clinics, nursing homes, schools, and workplaces, wherever Internet access is available.

Recommended AI News: Full Harvest Secures $23 Million Series B to Reduce On-Farm Food Waste by Digitizing the Produce Supply Chain

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.